Shares of Canopy Growth Corporation (NASDAQ:CGC - Get Free Report) have received a consensus rating of "Hold" from the five ratings firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company.
A number of equities analysts have weighed in on CGC shares. Wall Street Zen downgraded Canopy Growth from a "hold" rating to a "sell" rating in a research report on Saturday. Weiss Ratings upgraded Canopy Growth from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Wednesday, August 26th.
Get Our Latest Stock Report on CGC
Canopy Growth Stock Performance
Shares of CGC opened at $0.97 on Friday. The company has a market cap of $437.03 million, a PE ratio of -2.16 and a beta of 0.83. The firm has a 50-day moving average of $0.97 and a 200-day moving average of $1.03. Canopy Growth has a one year low of $0.84 and a one year high of $2.38. The company has a debt-to-equity ratio of 0.31, a current ratio of 3.04 and a quick ratio of 2.39.
Canopy Growth (NASDAQ:CGC - Get Free Report) last issued its earnings results on Friday, August 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.04) by $0.02. Canopy Growth had a negative net margin of 65.33% and a negative return on equity of 21.91%. The company had revenue of $142.62 million for the quarter, compared to analysts' expectations of $58.21 million. As a group, equities analysts forecast that Canopy Growth will post -0.1 earnings per share for the current year.
Insider Buying and Selling at Canopy Growth
In other news, CEO Luc Mongeau sold 135,231 shares of the stock in a transaction dated Wednesday, June 17th. The shares were sold at an average price of $0.97, for a total value of $131,174.07. Following the transaction, the chief executive officer directly owned 1,723,913 shares of the company's stock, valued at $1,672,195.61. This represents a 7.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Christelle Gedeon sold 58,994 shares of the stock in a transaction dated Wednesday, June 17th. The shares were sold at an average price of $0.97, for a total transaction of $57,224.18. Following the completion of the transaction, the insider directly owned 705,506 shares in the company, valued at $684,340.82. The trade was a 7.72% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 240,533 shares of company stock worth $240,032. Corporate insiders own 0.35% of the company's stock.
Institutional Investors Weigh In On Canopy Growth
Several hedge funds have recently bought and sold shares of CGC. Lazard Asset Management LLC bought a new position in shares of Canopy Growth during the first quarter worth approximately $1,716,000. Northwestern Mutual Wealth Management Co. boosted its stake in Canopy Growth by 19,571.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,022,197 shares of the company's stock valued at $2,305,000 after purchasing an additional 2,011,917 shares during the period. Royal Bank of Canada boosted its stake in Canopy Growth by 1,115.6% in the 1st quarter. Royal Bank of Canada now owns 975,967 shares of the company's stock valued at $927,000 after purchasing an additional 895,680 shares during the period. Caitong International Asset Management Co. Ltd grew its holdings in Canopy Growth by 723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 4,595,330 shares of the company's stock valued at $5,239,000 after buying an additional 4,037,281 shares in the last quarter. Finally, Foundations Investment Advisors LLC acquired a new position in Canopy Growth in the 4th quarter valued at $485,000. 3.33% of the stock is currently owned by institutional investors and hedge funds.
Canopy Growth Company Profile
(
Get Free Report)
Canopy Growth Corporation is a leading Canadian cannabis company engaged in the production, distribution and sale of both medical and recreational cannabis products. Headquartered in Smiths Falls, Ontario, the company cultivates a diversified portfolio of offerings that includes dried flower, pre-rolled joints, oils, softgel capsules and edibles. Canopy Growth also markets derivative products such as beverages and wellness formulations under a range of brands, aiming to serve both patient and adult-use markets.
The company operates through multiple subsidiaries, including Tweed Inc, Spectrum Therapeutics and Tokyo Smoke, each targeting distinct consumer segments.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.